<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1887-8571</journal-id>
<journal-title><![CDATA[Sanidad Militar]]></journal-title>
<abbrev-journal-title><![CDATA[Sanid. Mil.]]></abbrev-journal-title>
<issn>1887-8571</issn>
<publisher>
<publisher-name><![CDATA[Ministerio de Defensa]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1887-85712018000400236</article-id>
<article-id pub-id-type="doi">10.4321/s1887-85712018000400005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación positiva de medicamentos: mayo, junio y julio 2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Positive assessment of drugs: May, June and July 2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Morán]]></surname>
<given-names><![CDATA[MªJ]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabanes Mariscal]]></surname>
<given-names><![CDATA[MªÁ]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aparicio Hernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Luque]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Central de la Defensa Gómez Ulla Servicio de Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Central de la Defensa Gómez Ulla Servicio de Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>not normalized</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Central de la Defensa Gómez Ulla Servicio de Farmacología Clínica ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>not normalized</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Central de la Defensa Gómez Ulla Servicio de Farmacología Clínica ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>not normalized</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>74</volume>
<numero>4</numero>
<fpage>236</fpage>
<lpage>247</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1887-85712018000400236&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1887-85712018000400236&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1887-85712018000400236&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Se reseñan los medicamentos evaluados y con dictamen positivo por comisión de expertos de la Agencia Española de Medicamentos y Productos Sanitarios o de la Agencia Europea del Medicamento hechos públicos en mayo, junio y julio de 2018, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in May, June and July of 2018, and considered of interest to the healthcare professional, are reviewed here. These are positive technical reports prior to the authorization and placing on the market of the product.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Abemaciclib (Verzenios®)]]></kwd>
<kwd lng="es"><![CDATA[Adalumumab (Halimatoz®, Hefiya®, Hyrimoz®, Hulio®)]]></kwd>
<kwd lng="es"><![CDATA[Binimetinib (Mektovi®)]]></kwd>
<kwd lng="es"><![CDATA[Caplacizumab (Cablivi®)]]></kwd>
<kwd lng="es"><![CDATA[Durvalumab (Imfinzi®)]]></kwd>
<kwd lng="es"><![CDATA[Encorafenib (Braftovi®)]]></kwd>
<kwd lng="es"><![CDATA[Erenumab (Aimovig®)]]></kwd>
<kwd lng="es"><![CDATA[Eravaciclina (Xevara®)]]></kwd>
<kwd lng="es"><![CDATA[Inotersen (Tegsedi®)]]></kwd>
<kwd lng="es"><![CDATA[Lesinurad/alopurinol (Duzallo®)]]></kwd>
<kwd lng="es"><![CDATA[Melatonina (slenyto®)]]></kwd>
<kwd lng="es"><![CDATA[Metreleptina (Myaleota®)]]></kwd>
<kwd lng="es"><![CDATA[Neratinib (Nerlynx®)]]></kwd>
<kwd lng="es"><![CDATA[Patisiran (Onpattro®)]]></kwd>
<kwd lng="es"><![CDATA[Pegfilgrastim (Pelgraz®)]]></kwd>
<kwd lng="es"><![CDATA[Pegfilgrastim (Udenyca®)]]></kwd>
<kwd lng="es"><![CDATA[Tezacaftor/ivacaftor (Symkevi®)]]></kwd>
<kwd lng="es"><![CDATA[Tildrakizumab (Ilumetri®)]]></kwd>
<kwd lng="es"><![CDATA[Tisagenlecleucel (Kymriah®)]]></kwd>
<kwd lng="es"><![CDATA[Trastuzumab (Trazimera®)]]></kwd>
<kwd lng="es"><![CDATA[Vestronidasa alfa (Mepsevii®)]]></kwd>
<kwd lng="es"><![CDATA[Vigabatrina (Kigabeq®)]]></kwd>
<kwd lng="es"><![CDATA[Vonicog alfa (Veyvondi®)]]></kwd>
<kwd lng="es"><![CDATA[Daunorubicina/citarabina (Vyxeos)]]></kwd>
<kwd lng="es"><![CDATA[Axicabtagen ciloleucel (Yescarta®)]]></kwd>
<kwd lng="en"><![CDATA[Abemaciclib (Verzenios®)]]></kwd>
<kwd lng="en"><![CDATA[Adalumumab (Halimatoz®, Hefiya®, Hyrimoz®, Hulio®)]]></kwd>
<kwd lng="en"><![CDATA[Binimetinib (Mektovi®)]]></kwd>
<kwd lng="en"><![CDATA[Caplacizumab (Cablivi®)]]></kwd>
<kwd lng="en"><![CDATA[Durvalumab (Imfinzi®)]]></kwd>
<kwd lng="en"><![CDATA[Encorafenib (Braftovi®)]]></kwd>
<kwd lng="en"><![CDATA[Erenumab (Aimovig®)]]></kwd>
<kwd lng="en"><![CDATA[Eravaciclina (Xevara®)]]></kwd>
<kwd lng="en"><![CDATA[Inotersen (Tegsedi®)]]></kwd>
<kwd lng="en"><![CDATA[Lesinurad/alopurinol (Duzallo®)]]></kwd>
<kwd lng="en"><![CDATA[Melatonina(slenyto®)]]></kwd>
<kwd lng="en"><![CDATA[Metreleptina (Myaleota®)]]></kwd>
<kwd lng="en"><![CDATA[Neratinib (Nerlynx®)]]></kwd>
<kwd lng="en"><![CDATA[Patisiran (Onpattro®)]]></kwd>
<kwd lng="en"><![CDATA[Pegfilgrastim (Pelgraz®)]]></kwd>
<kwd lng="en"><![CDATA[Pegfilgrastim (Udenyca®)]]></kwd>
<kwd lng="en"><![CDATA[Tezacaftor/ivacaftor (Symkevi®)]]></kwd>
<kwd lng="en"><![CDATA[Tildrakizumab (Ilumetri®)]]></kwd>
<kwd lng="en"><![CDATA[Tisagenlecleucel (Kymriah®)]]></kwd>
<kwd lng="en"><![CDATA[Trastuzumab (Trazimera®)]]></kwd>
<kwd lng="en"><![CDATA[Vestronidasa alfa (Mepsevii®)]]></kwd>
<kwd lng="en"><![CDATA[Vigabatrina (Kigabeq®)]]></kwd>
<kwd lng="en"><![CDATA[Vonicog alfa (Veyvondi®)]]></kwd>
<kwd lng="en"><![CDATA[Daunorubicina/citarabina (Vyxeos)]]></kwd>
<kwd lng="en"><![CDATA[Axicabtagen ciloleucel (Yescarta®)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Informe mensual sobre medicamentos de Uso Humano y Productos Sanitario]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Verzenius]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Informe mensual sobre medicamentos de Uso Humano y Productos Sanitario]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Halimatoz]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Hefiya]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Hyrimoz]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Hulio]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Mektovy]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Informe mensual sobre medicamentos de Uso Humano y Productos Sanitario]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Cablivi]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Imfinzi]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Braftori]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Aimovig]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Xerava]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Inotersen]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Duzallo]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Duzallo]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Slenyto]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Myalepta]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Nerlynx]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Onpattro]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Kymriah]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Mepsevii]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Veyvondi]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="">
<source><![CDATA[Documento EMA sobre Yescarta]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
